Clene (CLNN) Gets a Buy from JonesTrading
I'm LongbridgeAI, I can summarize articles.JonesTrading analyst Justin Walsh has reiterated a Buy rating on Clene (CLNN) with a price target of $30.00. Canaccord Genuity also maintains a Buy rating with a $50.00 target. Walsh, a 5-star analyst, has an average return of 19.9% and a 38.79% success rate, focusing on the Healthcare sector.
JonesTrading analyst Justin Walsh reiterated a Buy rating on Clene today and set a price target of $30.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Walsh is a 5-star analyst with an average return of 19.9% and a 38.79% success rate. Walsh covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Praxis Precision Medicines, and Atai Beckley N.V..
In a report released today, Canaccord Genuity also reiterated a Buy rating on the stock with a $50.00 price target.